A similar comparison was carried out for HER-2, where a significant difference in gene expression was found according to the HER-2 status assessed by IHC, with the cancers classed as IHC 3+ having a greater expression value (p = 0.022, Fig. 1). The gene discussed is ERBB2; the disease is cancer.